title: Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
authors.forename: Jorge G
authors.initials: JG
authors.lastname: Paez
authors.forename: Anna S
authors.initials: AS
authors.lastname: Levin
authors.forename: Mariusa
authors.initials: M
authors.lastname: Basso
authors.forename: Laura B
authors.initials: LB
authors.lastname: Gomez
authors.forename: Satiko
authors.initials: S
authors.lastname: Gobara
authors.forename: Fernanda
authors.initials: F
authors.lastname: Spadão
authors.forename: Isabel
authors.initials: I
authors.lastname: Oshiro
authors.forename: Silvia Figueiredo
authors.initials: SF
authors.lastname: Costa
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000453:epidemiology* / Q000382:microbiology; D001938:Brazil / Q000453:epidemiology; D015780:Carbapenems / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology* / Q000382:microbiology; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D020615:Stenotrophomonas maltophilia; D047090:beta-Lactams / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D002511:Cephalosporins; D047090:beta-Lactams